Real-time Observation of Leukocyte-endothelium Interactions in Tissue-engineered Blood Vessel
Overview
Chemistry
Affiliations
Human cell-based 3D tissue constructs play an increasing role in disease modeling and drug screening. Inflammation, atherosclerosis, and many autoimmune disorders involve the interactions between immune cells and blood vessels. However, it has been difficult to image and model these interactions under realistic conditions. In this study, we fabricated a perfusion and imaging chamber to allow the real-time visualization of leukocyte perfusion, adhesion, and migration inside a tissue-engineered blood vessel (TEBV). We monitored the elevated monocyte adhesion to the TEBV wall and transendothelial migration (TEM) as the TEBV endothelium was activated by the inflammatory cytokine TNF-α. We demonstrated that treatment with anti-TNF-α or an NF-kB signaling pathway inhibitor would attenuate the endothelium activation and reduce the number of leukocyte adhesion (>74%) and TEM events (>87%) close to the control. As the first demonstration of real-time imaging of dynamic cellular events within a TEBV, this work paves the way for drug screening and disease modeling in TEBV-associated microphysiological systems.
Innovative Atherosclerosis Models: Advancing Pathophysiology and Translational Research.
Jiang H, Liao Y, Zhu M, Jiramonai L, Wu H, Zhong Y Research (Wash D C). 2025; 8:0617.
PMID: 40046514 PMC: 11881979. DOI: 10.34133/research.0617.
Dasgupta I, Rangineni D, Abdelsaid H, Ma Y, Bhushan A Bioengineering (Basel). 2024; 11(5).
PMID: 38790343 PMC: 11117503. DOI: 10.3390/bioengineering11050476.
Vuong T, Bartolf-Kopp M, Andelovic K, Jungst T, Farbehi N, Wise S Adv Sci (Weinh). 2024; 11(26):e2307627.
PMID: 38704690 PMC: 11234431. DOI: 10.1002/advs.202307627.
Atherosclerotic three-layer nanomatrix vascular sheets for high-throughput therapeutic evaluation.
Chen J, Zhang X, Cross Jr R, Ahn Y, Huskin G, Evans W Biomaterials. 2024; 305():122450.
PMID: 38169190 PMC: 10843643. DOI: 10.1016/j.biomaterials.2023.122450.
Cardiovascular Tissue Engineering Models for Atherosclerosis Treatment Development.
Tscheuschner L, Tzafriri A Bioengineering (Basel). 2023; 10(12).
PMID: 38135964 PMC: 10740643. DOI: 10.3390/bioengineering10121373.